This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Isaac Goncalves: Innovator in Anti-Thrombotic Therapy
Introduction
Isaac Goncalves is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of pharmacology, particularly in the development of anti-thrombotic therapies. With a total of two patents to his name, Goncalves is recognized for his innovative approaches to medical treatments.
Latest Patents
Goncalves' latest patents focus on the inhibition of phosphoinositide 3-kinase β. The inventions relate to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are utilized in anti-thrombotic therapy. His work includes methods for screening compounds that demonstrate selective inhibitory activity of PI 3-kinase β. Additionally, the patents encompass novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Isaac Goncalves is currently employed at AstraZeneca, a leading global biopharmaceutical company. His role involves research and development in the area of therapeutic solutions, where he applies his expertise in pharmacology to create innovative treatments.
Collaborations
Goncalves has collaborated with notable colleagues such as Shaun P. Jackson and Alan Duncan Robertson. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Isaac Goncalves is a prominent inventor whose work in anti-thrombotic therapy has the potential to impact medical treatments significantly. His innovative patents and collaborations highlight his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile